These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7233887)

  • 1. Follow-up studies of healthy blood donors. Anti-HBs antibody carriers.
    Slusarczyk J; Cianciara J; Swiderska H; Loch T
    Vox Sang; 1981 Feb; 40(2):91-4. PubMed ID: 7233887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological studies on healthy blood donors hepatitis B antibody carriers.
    Cianciara J; Swiderska H; Slusarczyk J; Loch T
    Vox Sang; 1977 Aug; 33(2):88-92. PubMed ID: 302063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis markers in blood donors and patients with a history of jaundice.
    Follett EA; Barr A; Crawford RJ; Mitchell R
    Lancet; 1980 Feb; 1(8162):246-9. PubMed ID: 6101690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis and hepatitis B surface antigen and antibody in dentists.
    Berris B; Feinman SV; Sinclair JC; Wrobel D
    Can Med Assoc J; 1978 Nov; 119(9):1040-3. PubMed ID: 743666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen and antibody in asymptomatic blood donors.
    Sinclair JC; Feinman SV; Wrobel DM; Berris B
    JAMA; 1976 Mar; 235(10):1014-7. PubMed ID: 946183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.
    Hoofnagle JH; Gerety RJ; Ni LY; Barker LF
    N Engl J Med; 1974 Jun; 290(24):1336-40. PubMed ID: 4827644
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: New tests for hepatitis B virus.
    Zuckerman AJ
    N Engl J Med; 1974 Jun; 290(24):1373-4. PubMed ID: 4827646
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].
    Knolle J; Born M; Hess G; Klinge O; Arnold W; Bitz H; Meyer KH
    Klin Wochenschr; 1976 Jun; 54(12):567-78. PubMed ID: 781393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.
    Barr A; Black SH; Burrell CJ; Dow B; Macvarish I
    J Clin Pathol; 1979 Feb; 32(2):132-5. PubMed ID: 108319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and persistence of serologic markers following three different manifestations of hepatitis B virus infection.
    Wilkinson R
    Vox Sang; 1983; 45(2):121-8. PubMed ID: 6613079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.
    Cheung WI; Lin SY; Leung VK; Fung KS; Lam YK; Lo FH; Chau TN
    Hong Kong Med J; 2011 Oct; 17(5):376-80. PubMed ID: 21979474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.
    Madalinski K; Burczynska B; Heermann KH; Uy A; Gerlich WH
    Clin Exp Immunol; 1991 Jun; 84(3):493-500. PubMed ID: 2044231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.